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ABSTRACT
Introduction As the world continues to grapple with the 
COVID-19 pandemic, emerging evidence suggests that 
individuals from ethnic minority backgrounds may be 
disproportionately affected. The United Kingdom Research 
study into Ethnicity And COVID-19 outcomes in Healthcare 
workers (UK- REACH) project has been initiated to generate 
rapid evidence on whether and why ethnicity affects 
COVID-19 diagnosis and clinical outcomes in healthcare 
workers (HCWs) in the UK, through five interlinked work 
packages/work streams, three of which form the basis 
of this protocol. The ethico- legal work (Work Package 
3) aims to understand and address legal, ethical and 
acceptability issues around big data research; the HCWs' 
experiences study (Work Package 4) explores their work 
and personal experiences, perceptions of risk, support and 
coping mechanisms; the stakeholder engagement work 
(Work Package 5) aims to provide feedback and support 
with the formulation and dissemination of the project 
recommendations.
Methods and analysis Work Package 3 has two different 
research strands: (A) desk- based doctrinal research; 
and (B) empirical qualitative research with key opinion 
leaders. For the empirical research, in- depth interviews 
will be conducted digitally and recorded with participants’ 
permission. Recordings will be transcribed, coded and 
analysed using thematic analysis. In Work Package 4, online 
in- depth interviews and focus groups will be conducted with 
approximately 150 HCWs, from across the UK, and these will 
be recorded with participants’ consent. The recordings will 
be transcribed and coded and data will be analysed using 
thematic analysis. Work Package 5 will achieve its objectives 
through regular group meetings and in- group discussions.
Ethics and dissemination Ethical approval has been 
received from the London- Brighton & Sussex Research 
Ethics Committee of the Health Research Authority (Ref 
No 20/HRA/4718). Results of the study will be published 
in open- access journals, and disseminated through 
conference presentations, project website, stakeholder 
organisations, media and scientific advisory groups.
Trial registration number ISRCTN11811602.
INTRODUCTION
Since the start of the COVID-19 pandemic in 
December 2019 in China, the SARS- CoV-2 has 
spread rapidly to almost all parts of the world, 
infecting officially, and to date, more than 
170 million people and claiming around 3.5 
Strengths and limitations of this study
 ► Doctrinal and empirical research (Work Package 3) 
to understand ethical and legal implications in big 
data health research is novel to the UK Research 
Study into Ethnicity and COVID-19 Outcomes in 
Healthcare Workers (UK- REACH) study and has po-
tential to inform policy and practice in the area.
 ► UK- REACH is the first comprehensive qualitative 
research (Work Package 4) with healthcare work-
ers, particularly from ethnic minority backgrounds, 
in the UK exploring their experiences during the 
COVID-19 pandemic and perceptions of risk and 
coping mechanisms.
 ► The engagement of stakeholders (Work Package 5) 
in every stage of UK- REACH is exemplary and pro-
vides real- world relevance to the research and the 
findings.
 ► As the ethico- legal empirical research will recruit 
key opinion leaders (and not members of the wider 
population), the demographic diversity of the sam-
ple and the opinions gathered in interview may be 
limited by the characteristics of those in leadership 
positions in the field.
 ► Due to the pandemic restrictions, interviews and fo-
cus group discussions will be conducted via online 
methods as a substitute for face- to- face meetings, 
posing practical and technological challenges for 
dynamic interaction with participants.
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million lives.1 As the world continues to fight against this 
novel virus, there is emerging evidence that ethnicity may 
be an important risk factor in COVID-19 infection, disease 
and mortality.2–4 In the UK, people from ethnic minority 
communities have been found to be disproportionately 
affected by COVID-19.5–9 Ethnic differences in COVID-19 
outcomes have become significant because of the grave 
medical and clinical concerns, and due to accompanying 
issues of marginalisation and health inequities affecting 
these communities, which predate the pandemic.10 
Urgent calls had, therefore, been made to incorporate 
ethnicity into COVID-19 research, although with caution 
to adopt a holistic view of ethnicity.11 12 While research 
on ethnicity and COVID-19 has since progressed,13 14 its 
interplay with other crucial risk factors, such as occupa-
tion, remains scantily explored.
Occupational risk has been identified as a contrib-
uting factor in COVID-19 morbidity and mortality, with 
healthcare workers (HCWs) accounting for a large 
proportion of the total case load.15 The increased burden 
of SARS- CoV-2 infection on HCWs and their families, 
particularly those from an ethnic minority background, 
has been reported, raising further concerns about the 
protection of those most at risk.16–19 Potential explana-
tions for increased risk among HCWs have mostly been 
attributed to patient- facing roles, lack of personal protec-
tive equipment, long working hours and even lack of 
training.20 While these reasons may offer partial explana-
tion, they fail to explicate the high rates of infection and 
deaths among ethnic minority HCWs. In their analysis of 
deaths from COVID-19 among National Health Service 
(NHS) workers in the UK, Cook et al point out that while 
ethnic minority workers constitute about 21% of the 
NHS workforce, they have accounted for nearly 63% of 
the total deaths.19 These differential outcomes make an 
urgent case for exploring if, how and why ethnicity affects 
COVID-19 diagnosis and clinical outcomes in HCWs, with 
special reference to HCWs from ethnic minority groups.
The United Kingdom Research study into Ethnicity 
And COVID-19 outcomes in Healthcare Workers 
(UK- REACH), led by the University of Leicester, has been 
initiated to fill this gap. This study has been badged as 
an Urgent Public Health study by the National Institute 
for Health Research, and will run until August 2021 to 
rapidly examine differences in COVID-19 diagnosis, clin-
ical outcomes, professional practices and physical and 
mental well- being among HCWs from different ethnic-
ities through five interlinked work packages (see www. 
uk- reach. org for more details). Work Package 1 is an anal-
ysis of a linked data set with anonymised health data on 
COVID-19 outcomes, among clinical and ancillary HCWs 
21 . Work Package 2 will establish a national longitudinal 
cohort of ethnic minority (with White ethnic group as 
comparator) HCWs and ancillary staff to assess changes 
in their health outcomes, social circumstances and profes-
sional roles over the course of the pandemic.22 In this 
article, we describe the doctrinal, qualitative and stake-
holder engagement protocol covering Work Packages 3–5 
(WP3–WP5) of the project, which will explore questions 
of ethics, law, risk perception and behaviours of HCWs in 
relation to COVID-19.
UK-REACH (WP3–WP5) objectives
The objectives of WP3–WP5 are to:
1. Undertake research to understand and address legal, 
ethical and social acceptability issues around data pro-
tection, privacy and information governance associat-
ed with the linkage of professionals’ registration data 
and healthcare data (WP3).
2. Undertake qualitative interviews and focus groups with 
HCWs to examine experiences, risk perceptions, cop-
ing and support and physical and mental well- being 
pertaining to COVID-19 (WP4).
3. Develop a multiprofessional, national stakeholder 
group to inform the conduct of the research, and fa-
cilitate rapid dissemination and translation of the re-
search findings into policy (WP5).
METHODS
Ethical and legal work package (WP3)
Study design
Research involving large data sets containing personal 
and health information raises legal, ethical and social 
issues surrounding the processing of such sensitive data, 
even when then the data are putatively anonymised. 
Understanding HCW concerns regarding trust, engage-
ment, risk perception, barriers to participation and confi-
dentiality is paramount for a project like UK- REACH to 
succeed and be conducted in a way that both respect 
participants’ rights and interests, and also hold ethics and 
law at the forefront of each research activity. To do so, we 
will undertake two different strands of research. First, we 
will undertake desk- based doctrinal research to identify 
the relevant legal and ethical issues and provide a policy 
report with ongoing recommendations for implementa-
tion within the project. Second, we will conduct empirical 
qualitative research with key opinion leaders to explore 
their views on the ethical and legal implications of large 
data set analyses/cohort studies, such as risks of reiden-
tification and identifying core principles of information 
governance in the context of sensitive data and HCW data 
sets. We explore each of these research strands in more 
detail below.
Desk-based research
The ethico- legal work will commence with a comprehen-
sive literature and doctrinal review based on consultation 
of relevant legal, regulatory and policy- based documents 
(conducted in part through consultation of the Westlaw 
legal database and the  legislation. gov. uk website) to 
identify the legal framework and ethical issues pertinent 
to UK- REACH. This will focus on concerns surrounding 
privacy, data protection and human rights, and how to 
ensure an ethical approach for UK- REACH, particu-
larly in the context of linking data concerning health-
care professionals’ employment, registration and 
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health. Key issues we will consider include the limits of 
anonymisation, the risks of reidentification, particular 
ethical concerns arising from the use of sensitive data 
concerning ethnicity and what appropriate safeguards 
can be considered.
From this, a comprehensive policy report will be formu-
lated to outline the key legal and ethical issues and 
provide recommendations for UK- REACH, to be deliv-
ered in month 3 of the project.
Empirical qualitative research
Study population
The proposed empirical qualitative research will have 
key opinion leaders (≥16 years of age) working in a 
healthcare and biomedical research, or in health- related 
organisations (such as regulatory bodies, royal colleges, 
trade unions). Approximately 15–20 participants will be 
purposively selected and recruited through gatekeepers, 
members of the UK- REACH research team, stakeholder 
group and snowballing.
Data collection
Data will be collected using a semistructured topic 
guide, which has been developed by ED in consultation 
with other investigators and the Professional Expert 
Panel (PEP), which is the public involvement group in 
UK- REACH. The topic guide will include key areas of 
inquiry, such as participants’ past experiences of research 
or knowledge of research processes, real or perceived 
barriers to research participation, views on current safe-
guards in law, policy and regulation around participants’ 
rights and interests, exploring how ethnicity and race 
may influence risks and stigmatisation in research, or 
perceptions of the same and, finally, to gather views on 
protection measures that can or should be put in place by 
law or policy to adequately protect research participants. 
Additionally, for purposes of describing the cohort, basic 
demographic information such as age, gender, job role 
and geographic location will be collected using a short 
demographic data template.
Interviews will be conducted by a member of the 
research team via Microsoft Teams, or via telephone, 
depending on the availability, preference, COVID-19 
limitations and/or work requirements of the participant. 
The interviews are likely to last between 45 and 60 min. 
Interviews will be recorded through the relevant platform 
software (eg, using the recording feature in Microsoft 
Teams) or on encrypted digital dictaphones, always with 
participants’ express written permission. As interviews 
are conducted orally, data will be transcribed and then 
anonymised prior to data analysis.
Analysis plan
Digital files of the recorded interviews will be immediately 
uploaded securely and transcribed in intelligent verbatim 
by a transcription specialist company. The transcripts will 
be anonymised by removing all identifying information 
that enables indirect or inferential identification. Once 
transcribed, we will compare the transcription with the 
recording to ensure accuracy.
The data from the interviews will be coded using quali-
tative thematic analysis. The process will consist of gener-
ating initial codes by comparing each of the transcripts. 
Coding is expected to be done manually and in multiple 
stages. We will adopt an inductive, data- driven approach 
and will begin with ‘open coding’, that is, reading each 
transcript (word by word and line by line). During the 
coding process, we will take notes in a memo- style format 
by writing down words and thoughts considered to be 
of use during the data analysis and serve as a reference 
for potential coding ideas. After completion of the open 
coding, initial codes will be constructed based on what 
emerged from the text, and we will proceed to code 
the remaining transcripts with those codes. When we 
encounter data that do not fit into an existing code, we 
will add new codes. We will then group the similar codes 
and place them into categories. These categories will be 
reorganised into broader, higher order categories, then 
grouped, revised and refined, and finally checked to 
determine whether the categories are mutually exclusive. 
At this point, we will form final categories, identifying 
subthemes both within and across the categories, which 
will then be organised into main themes.
Qualitative research on HCW experiences work package (WP4)
Study design
We will undertake qualitative research with HCWs to 
understand their experiences during the COVID-19 
pandemic. We will engage with clinical and ancillary staff 
from ethnic minority and White backgrounds working in 
healthcare settings (eg, front- line HCWs, ancillary staff 
working in hospitals, community practitioners) to gain 
insight into their perceptions around risk factors, support, 
coping mechanisms and their mental and physical health 
during the pandemic in order to inform response strate-
gies to reduce COVID-19 morbidity and mortality in these 
individuals. We will conduct semistructured interviews 
and focus groups, which will enable in- depth explora-
tions of individual participants’ experiences and perspec-
tives,23 and also facilitate discussion between participants 
to explore both shared and differing experiences and 
perspectives.24 25
Study population
Participants will consist of adult individuals (≥16 years of 
age) with capacity to consent, from ethnic minority and 
White backgrounds with experience of working in health-
care settings during COVID-19, including both clinical and 
ancillary staff. We will recruit a purposive sample and will 
aim for theoretical saturation, including approximately 
50 in- depth semistructured interviews and focus groups 
with a total of approximately 100 participants. Saturation 
describes the point at which no new data or insights are 
being gained from interviews or focus groups,26 and so 
it becomes methodologically unnecessary to continue 
recruiting new individuals. In total, we aim to recruit 
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approximately 150 participants from different ethnicities, 
genders, job roles, hospital trusts and health boards, and 
UK regions to obtain a diverse sample.
Data collection
We will recruit participants through collaborators/part-
ners/stakeholders, community organisations and NHS 
organisations throughout the country. We will promote 
our research through posters, which will be advertised 
on- site and digitally (eg, online, by email and social 
media). Interested individuals will be able to contact 
the research team directly via the information provided 
on the poster. We will also work with gatekeepers in 
our partner and NHS organisations, who will send out 
communications regarding UK- REACH’s qualitative 
research on HCW experiences to their networks or staff 
to facilitate recruitment. Additionally, a subset of cohort 
participants from the longitudinal cohort study (Work 
Package 2) who have given their consent to be contacted 
for further research will be invited to participate in the 
interviews/focus groups.
Semistructured interviews and focus groups will be 
conducted by the research team informed by a topic 
guide. The topic guide has been developed in consulta-
tion with the PEP members and piloted before commence-
ment of actual data collection to trial out the questions as 
well as the online processes. Key topics included in this 
guide are: exploring participants’ experiences of working 
during COVID-19; their fears and concerns at work and 
outside of work; perceived risk factors; challenges faced in 
accessing information to keep themselves safe; concerns 
around stigma, discrimination and racism; and iden-
tifying facilitators and coping mechanisms. To accom-
modate multiple participants, approximately 1.5 hours 
will be allocated to the focus groups compared with the 
45–60 min for the one- to- one interviews. Following their 
participation, a token payment will be given to HCWs in 
recognition of their contribution to the research.
The topic guide will be the same when engaging health-
care staff through focus groups or one- to- one interviews. 
As in WP3, we will also collect basic demographic infor-
mation about the participants using a short demographic 
data template. Interviews and focus groups will take place 
in a secure, virtual environment (eg, Microsoft Teams) or 
via telephone at a time that is convenient to the partici-
pants. Where prior consent is given, interviews and focus 
groups will be recorded through the relevant software 
platform (eg, using the recording feature in Microsoft 
Teams). Interview and focus group recordings will be 
transcribed by professional transcribers and pseudony-
mised before the start of analysis. The transcriptions will 
be supplemented with notes taken by the researchers 
during the interviews and focus groups.
Analysis plan
Interview transcripts will be analysed using thematic 
analysis. Thematic analysis involves identifying themes 
or patterns in the data, lending coherence and order to 
it.27 Following Braun and Clarke’s six stages of thematic 
analysis, we will read and re- read the transcripts to 
build familiarity with the data, generate initial codes 
to develop a coding framework, collate codes into 
broad themes, review the themes, define and name 
the themes and, finally, write up the themes in a report 
form.28 We will primarily adopt an open inductive 
approach to develop codes out of our data, but codes 
may also be developed from existing literature and/or 
previously conducted research.27 Coding of data will be 
performed by the research team using NVivo software, 
and three/four different members of the research team 
will triangulate the coding process for credibility and 
rigour. Coding and theme development will be carried 
out until data saturation is reached and no new themes 
are emerging.
Stakeholder engagement work package (WP5)
The rich diversity of the UK- REACH research will be 
complemented by a robust stakeholder involvement 
and engagement strategy, which has been in- built into 
the project (WP5) and conforms to the principles of (1) 
being receptive of public views and opinions, (2) collab-
orating and cocreating with the public, and (3) involving 
the public in wider dissemination of results. Within this 
work package, a stakeholder group (UK- REACH STAG) 
has been created to provide feedback and insights, and 
support in the formulation and propagation of the project 
recommendations. The group has membership from a 
range of partner stakeholder organisations (eg, General 
Medical Council, Nursing and Midwifery Council) and 
associations of ethnic minority professionals such as Fili-
pino Nurses Association- UK and Association of Pakistani 
Physicians in Northern Europe. The group will meet 
virtually, once a month, until the end of the project, 
and will be governed by a set of terms of reference. 
Group meetings will be chaired by a nominated HCW 
chairperson/deputy chairperson, and a member of the 
research team will help with the coordination. Common 
email forums may also be created for the group members 
to share their views, opinions and feedback among each 
other outside of the periodic meetings. Progress with the 
delivery of other work packages, and where needed input 
from a stakeholder perspective is sought through these 
meetings. The stakeholder group’s primary approach is 
through informal consensus building during the monthly 
meetings. Formal consensus approaches such as Delphi 
may be used if a more challenging decision need arises 
during the implementation of the project or for the 
purpose of optimising dissemination.
Views and opinions expressed by the group members 
will be aggregated, and individual names will not appear 
in any of the published documents. Meeting minutes will 
only be shared with the respective group members and 
on a need- to- know basis with members of the research 
team. The UK- REACH STAG will also provide support in 
the dissemination of the project recommendations.
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PATIENT AND PUBLIC INVOLVEMENT
Public involvement has been a central tenet in the 
UK- REACH project since its early stages. The project 
was developed in consultation and collaboration with 
national stakeholders including the General Medical 
Council, Nursing and Midwifery Council, royal colleges 
and ethnic minority HCW associations like British Associ-
ation of Physicians of Indian Origin. The public involve-
ment and engagement component has been further 
streamlined into the project with the creation of the PEP 
comprising healthcare professionals in various roles and 
from different ethnic backgrounds. The group members 
provide unique insight—relating to their professions and 
ethnic groups by virtue of their lived experiences—to 
certain aspects of the project. The PEP meets virtually 
and has provided inputs on the participant recruitment 
strategies for the different work packages, as well as ques-
tionnaire for the cohort study, topic guides for WP3 and 
WP4 and other study- related documents (eg, text within 
participant- facing items). We will continue to consult 
the PEP on other matters, such as data collection, anal-




Prior to focus groups and interviews, potential partici-
pants will be given participant information sheets (PIS), 
which will detail the nature of the research, objectives and 
any risks involved with participation. In light of COVID-19 
constraints regarding face- to- face interaction, consent 
will be sought digitally (ie, via a secure internet portal) 
from the participants and a downloadable version of the 
completed form will be available to participants for their 
record. The right to decline to participate, and to with-
draw consent at any stage of the research, will be explicitly 
stated on both the PIS and in discussion with potential 
participants. It will be explicitly stated that their signing 
of the consent form at no point supersedes their right 
to withdraw from the study. The PIS also states that if a 
participant withdraws from the study after collection of 
data, the collected data will be stored and analysed by the 
research team, unless the participant specifically requests 
for removal of the data at the time of withdrawal. The 
opportunity will also be given before every interview and 
focus group for participants to ask any questions about 
the scope of the research, or their rights as participants 
throughout the consent process.
Psychologically or emotionally distressing conversations
While this study is low risk, particularly with respect to 
WP3–WP5, we recognise that exploring and discussing 
experiences around COVID-19 and ethnicity (including 
issues of stigmatisation, structural injustice or racism) 
could be distressing to participants. We aim to manage 
this risk through the consent process, clearly explaining 
to individuals what the study entails, and giving ample 
opportunities to question the process and decline to take 
part if individuals wish. We also aim to make the interview 
process as comfortable as possible, and ensure partici-
pants know they may stop, take a break or decide to with-
draw from the interview and/or study at any point. The 
interview will always proceed at the comfort and discre-
tion of the participant.
Confidentiality and data protection
We will inform participants that participation will be 
confidential, and any personal information collected will 
be anonymised. Interview transcripts relating to individ-
uals will also be pseudonymised using a unique numer-
ical and date reference as the means to identify individual 
data sets. Such a system will ensure the anonymity of the 
participants and allow identification of individual data 
sets should a participant wish to exercise their individual 
rights (such as access, rectification or erasure). Individual 
data and transcripts will be held in secure digital drives, 
and original recordings will be deleted after transcrip-
tion. Access to the full data set will only be provided to 
the members of the research team. The only circum-
stance in which individual- level data will be released is 
in the form of deidentified, anonymised excerpts within 
the final publication, which is a standard procedure in 
qualitative research of this type.29 The excerpts will take 
the form of words, sentences and phrases the participants 
have provided which exemplify the coding framework 
and themes generated through the analysis.
Dissemination of results and recommendations
We will ensure that the findings from the work packages 
are reported rapidly and published on our public- facing 
website ( www. uk- reach. org). We have also enlisted the 
support of our stakeholders in disseminating the find-
ings and recommendations through their organisational 
websites, newsletters, internal communications, blogs or 
social media channels like Twitter. Following suggestions 
from our STAG members, we will also endeavour to make 
recommendations available in other languages such as 
Welsh, for greater uptake. In addition, we will make our 
findings available to the Scientific Advisory Group for 
Emergencies and other policymakers in a timely manner 
so that policy decisions can be made in near real time. As 
a topic of immense public health significance, we will also 
endeavour to make our results available through print 
and electronic media. We will also publish the outputs of 
this research in peer- reviewed journals in line with the 
University of Leicester’s Open Access publication policy 
to enable us to share the results widely with the academic 
community. We will also make presentations at relevant 
academic conferences as well as non- academic events 
organised by our collaborators.
DISCUSSION
UK- REACH, led by the University of Leicester, is 
one of the first studies in the world that sets out to 
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understand why HCWs from minority ethnic back-
grounds are disproportionately affected by COVID-19 
as compared with their White counterparts. While 
emerging evidence from epidemiological studies 
is pointing to varied COVID-19 outcomes among 
different ethnic groups, not much is known about the 
reasons behind this variation. The qualitative work 
packages of the project, that is, WP3 and WP4, are 
expected to generate evidence which will be crucial in 
understanding some of the ethnicity- linked risk factors 
in COVID-19. The aim of the stakeholder engagement 
work package is to disseminate this evidence widely and 
in a timely manner. Additionally, our ethico- legal work 
package will generate important guidance on ways to 
minimise risks associated with research participation, 
and best practices in protecting the rights and inter-
ests of participants. Through our qualitative study on 
HCW experiences we aim to increase knowledge about 
risk perceptions, support and coping mechanisms rele-
vant to COVID-19, which in turn will enable health-
care organisations to protect the mental and physical 
health of ethnic minority staff. We appreciate the 
insights that stakeholders can bring into our project 
and have enlisted their support from early on to maxi-
mise our reach and impact. It is the ultimate hope that 
through this project we will gain clear insight into the 
differences in COVID-19 clinical outcomes, profes-
sional practices and well- being among ethnic minority 
and White HCWs, in turn leading to a robust evidence 
basis for policymaking to minimise the impacts of 
COVID-19 on HCWs across the UK.
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